Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke.
Migliavacca M, Correa-Paz C, Pérez-Mato M, Bielawski PB, Zhang I, Marie P, Hervella P, Rubio M, Maysinger D, Vivien D, Del Pino P, Pelaz B, Polo E, Campos F.
Migliavacca M, et al. Among authors: maysinger d.
J Nanobiotechnology. 2024 Jan 3;22(1):10. doi: 10.1186/s12951-023-02206-5.
J Nanobiotechnology. 2024.
PMID: 38166940
Free PMC article.